Teva Pharma (TEVA) Said Near FTC Approval for $40.5B Allergan (AGN) Generics Deal - Bloomberg
Tweet Send to a Friend
(Updated)Teva Pharma (NYSE: TEVA) is close to winning FTC approval ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
